Related Experiment Video
Updated: Mar 8, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in
Liu-Ya Tang1, Mary Heller1, Zhaojing Meng2
1From the Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892 and.
Abstract:
Transforming growth factor-β (TGF-β) signals through both SMAD and non-SMAD pathways to elicit a wide array of biological effects. Existing data have shown the association and coordination between STATs and SMADs in mediating TGF-β functions in hepatic cells, but it is not clear how STATs are activated under these circumstances. Here, we report that JAK1 is a constitutive TGFβRI binding protein and is absolutely required for phosphorylation of STATs in a SMAD-independent manner within minutes of TGF-β stimulation. Following the activation of SMADs, TGF-β also induces a second phase of STAT phosphorylation that requires SMADs, de novo protein synthesis, and contribution from JAK1. Our global gene expression profiling indicates that the non-SMAD JAK1/STAT pathway is essential for the expression of a subset of TGF-β target genes in hepatic stellate cells, and the cooperation between the JAK1-STAT3 and SMAD pathways is critical to the roles of TGF-β in liver fibrosis.
Insights
Transforming growth factor-β (TGF-β) activates STATs through a SMAD-independent JAK1 pathway within minutes. A second SMAD-dependent phase requires protein synthesis, with JAK1/STAT3 and SMADs cooperating in liver fibrosis.
Area of Science:
- Cellular biology
- Molecular signaling
- Hepatology
Background:
- Transforming growth factor-β (TGF-β) mediates diverse biological effects via SMAD and non-SMAD pathways.
- STATs and SMADs coordinate TGF-β functions in hepatic cells, but STAT activation mechanisms remain unclear.
Purpose of the Study:
- To elucidate the mechanism of STAT activation by TGF-β in hepatic cells.
- To investigate the role of JAK1 and SMADs in TGF-β-induced STAT phosphorylation.
- To determine the contribution of the JAK1/STAT pathway to TGF-β target gene expression and liver fibrosis.
Main Methods:
- Investigated JAK1 as a TGFβRI binding protein.
- Assessed STAT phosphorylation in a SMAD-independent manner following TGF-β stimulation.
- Analyzed a second phase of STAT phosphorylation requiring SMADs and de novo protein synthesis.
- Utilized global gene expression profiling in hepatic stellate cells.
Main Results:
- JAK1 is constitutively bound to TGFβRI and essential for rapid, SMAD-independent STAT phosphorylation upon TGF-β stimulation.
- A secondary phase of STAT phosphorylation occurs later, dependent on SMADs and de novo protein synthesis, with JAK1 involvement.
- The non-SMAD JAK1/STAT pathway is crucial for a subset of TGF-β target genes in hepatic stellate cells.
- Cooperation between JAK1-STAT3 and SMAD pathways is vital for TGF-β's role in liver fibrosis.
Conclusions:
- JAK1 mediates an early, SMAD-independent STAT activation by TGF-β.
- A later, SMAD-dependent STAT activation phase also involves JAK1 and protein synthesis.
- The JAK1/STAT3 and SMAD pathways cooperate to drive TGF-β-induced liver fibrosis.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Related Concept Videos
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply